Letters NICE on bacterial meningitis

Vancomycin may not be necessary

BMJ 2010; 341 doi: http://dx.doi.org/10.1136/bmj.c4704 (Published 27 August 2010) Cite this as: BMJ 2010;341:c4704
  1. Katherine L Henderson, scientist (epidemiology)1,
  2. Berit Muller-Pebody, scientist (epidemiology)1,
  3. Shamez Ladhani, paediatric infectious diseases consultant12,
  4. Mike Sharland, paediatric infectious diseases consultant2,
  5. Alan P Johnson, consultant clinical scientist1
  1. 1Centre for Infections, Health Protection Agency, London NW9 5EQ
  2. 2Paediatric Infectious Disease Unit, St George’s Hospital, London SW17 0QT
  1. Katherine.Henderson{at}hpa.org.uk

    The guidelines from the National Institute for Health and Clinical Excellence (NICE) on the empirical treatment of bacterial meningitis in children recommend intravenous ceftriaxone for children aged ≥3 months and cefotaxime plus ampicillin or amoxicillin for infants aged ≥3 months.1 2 The British National Formulary for Children (BNF-C) recommends similar empirical treatment with cefotaxime or cefotaxime and ampicillin, respectively.3 Whereas the BNF-C …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial